APVO Aptevo Therapeutics Inc.
Healthcare$4.89-1.21%ClosedMarket Cap: $10.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.45
P/S
0.00
EV/EBITDA
-0.03
DCF Value
$5,118.37
FCF Yield
-249.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-198.5%
ROA
-131.9%
ROIC
-166.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-6.8M | $-6.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.0M | $-5.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-26.3M | $-26.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.6M | $-7.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.2M | $-6.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.5M | $-6.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.4M | $-6.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-24.6M | $-24.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.2M | $-5.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.0M | $-5.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-7.0M | $-6.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-6.4M | $-5.9M | $-177,705.00 | — |